BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Agility or Corner-Cutting? Asia's Accelerated-Approval Gamble

On 1 April 2026, Japan's Pharmaceuticals and Medical Devices Agency did something no other major medicines regulator had done before it: from that date, ev...

June 16, 2026 | Analysis

Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme

-- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate...

June 15, 2026 | News

Akeso Expands Immunology Franchise with Approval of Gumokimab for Psoriasis

Akeso, Inc. announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-devel...

June 15, 2026 | News

Simcere and Stanford Medicine Partner to Advance First-in-Class Therapy for Idiopathic Pulmonary Fibrosis

Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory stu...

June 15, 2026 | News

Mabwell's First In Class Autoimmune Antibody 9MW5211 Wins China Clinical Trial Approval for IBD

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently...

June 08, 2026 | News

CAS Brings Trusted Scientific Intelligence Directly Into R&D Workflows Through New Connections Framework

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced CAS Connections, a new integration framework th...

June 05, 2026 | News

Advancing NAD Biomarkers From Research Discovery To Clinical Reality

As interest in metabolic health, longevity science, and precision medicine continues to grow, the ability to accurately measure biological markers linked t...

June 03, 2026 | Interview

Thermo Fisher Scientific Simplifies Nucleic Acid Verification With New E Gel Power Snap Lite System

Thermo Fisher Scientific announced the launch of the Invitrogen™ E-Gel™ Power Snap Lite Electrophoresis System, a compact, all-in-one solution ...

June 03, 2026 | News

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” ...

June 02, 2026 | Analysis

Caliway Advances Global Phase 3 Programme For CBL 514 Following U.S. FDA IND Clearance

Asia-Pacific Phase 2 Study CBL-0206 Also Approved by Australia HREC and Taiwan TFDA, Accelerating Global Dual-Track Strategy ...

May 26, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

May 26, 2026 | News

SN BioScience Inc. Initiates Global Phase 1b/2 Trial Of SNB 101 In Extensive Stage Small Cell Lung Cancer

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...

May 18, 2026 | News

Piramal Pharma Solutions Expands US ADC Manufacturing Capability With New Payload Linker Suite In Michigan

The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized...

May 15, 2026 | News

ACROBiosystems Expands Global Licensing Access For HEK293 Functional Cell Lines

ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global ...

May 12, 2026 | News

Stay Connected